Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives

Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives

US Patent 9643983 · Granted May 9, 2017

Estimated economic value: $37,368,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modulators of TMEM16A for treating respiratory disease2025
Compounds2025
Solid forms of n-tert-butyl-4[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino]pyridin2025
N-acyl-{4-[(4-aryl-phenyl)sulfonylmethyl]piperidine} compounds and their therape2024
NLRP3 inflammasome inhibitors2024
Bicyclic indazole glucocorticoid receptor antagonists2024
Pyridine and pyrazine derivative for the treatment of chronic bronchitis2024
Pyridine and pyrazine derivative for the treatment of chronic bronchitis2024
Pyridine and pyrazine derivative for the treatment of chronic bronchitis2024
Meta tyrosine derivatives as rho-kinase inhibitors2023
Carboxamide derivatives2023
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer2023